Hanxi Wang, Li Li, Lihan Luo, Yuqi Cheng, Feng Zhou, ShuangJun Zhao, Yang Li, Yuzhu Yang, Qianqian Zhou, Hanyun Niu, Jiannan He, Cao Zhang, Jian Guo, Longguang Tang, Jianhong Xu
{"title":"用于心肌缺血再灌注损伤靶向治疗的先进纳米材料平台。","authors":"Hanxi Wang, Li Li, Lihan Luo, Yuqi Cheng, Feng Zhou, ShuangJun Zhao, Yang Li, Yuzhu Yang, Qianqian Zhou, Hanyun Niu, Jiannan He, Cao Zhang, Jian Guo, Longguang Tang, Jianhong Xu","doi":"10.34133/research.0822","DOIUrl":null,"url":null,"abstract":"<p><p>Ischemic heart disease (IHD) remains a major global health challenge due to its persistently high incidence and mortality rates. Although early thrombolytic or interventional therapy reduces infarct size, myocardial ischemia-reperfusion injury (MIRI) often occurs when restoring blood flow to ischemic myocardium, paradoxically causing cardiomyocyte death. Unlike conventional cardioprotective agents, bioengineered nanomaterials enable targeted drug delivery to ischemic cardiomyocytes through tunable physicochemical properties. This improves therapeutic efficacy while reducing systemic exposure, providing innovative strategies for MIRI treatment. This review summarizes recent advances in nanomaterial-based MIRI therapies and critically evaluates their clinical translation potential, highlighting both opportunities and challenges.</p>","PeriodicalId":21120,"journal":{"name":"Research","volume":"8 ","pages":"0822"},"PeriodicalIF":10.7000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324810/pdf/","citationCount":"0","resultStr":"{\"title\":\"Advanced Nanomaterial Platforms for Targeted Therapy of Myocardial Ischemia-Reperfusion Injury.\",\"authors\":\"Hanxi Wang, Li Li, Lihan Luo, Yuqi Cheng, Feng Zhou, ShuangJun Zhao, Yang Li, Yuzhu Yang, Qianqian Zhou, Hanyun Niu, Jiannan He, Cao Zhang, Jian Guo, Longguang Tang, Jianhong Xu\",\"doi\":\"10.34133/research.0822\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Ischemic heart disease (IHD) remains a major global health challenge due to its persistently high incidence and mortality rates. Although early thrombolytic or interventional therapy reduces infarct size, myocardial ischemia-reperfusion injury (MIRI) often occurs when restoring blood flow to ischemic myocardium, paradoxically causing cardiomyocyte death. Unlike conventional cardioprotective agents, bioengineered nanomaterials enable targeted drug delivery to ischemic cardiomyocytes through tunable physicochemical properties. This improves therapeutic efficacy while reducing systemic exposure, providing innovative strategies for MIRI treatment. This review summarizes recent advances in nanomaterial-based MIRI therapies and critically evaluates their clinical translation potential, highlighting both opportunities and challenges.</p>\",\"PeriodicalId\":21120,\"journal\":{\"name\":\"Research\",\"volume\":\"8 \",\"pages\":\"0822\"},\"PeriodicalIF\":10.7000,\"publicationDate\":\"2025-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324810/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.34133/research.0822\",\"RegionNum\":1,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Multidisciplinary\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.34133/research.0822","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Multidisciplinary","Score":null,"Total":0}
Advanced Nanomaterial Platforms for Targeted Therapy of Myocardial Ischemia-Reperfusion Injury.
Ischemic heart disease (IHD) remains a major global health challenge due to its persistently high incidence and mortality rates. Although early thrombolytic or interventional therapy reduces infarct size, myocardial ischemia-reperfusion injury (MIRI) often occurs when restoring blood flow to ischemic myocardium, paradoxically causing cardiomyocyte death. Unlike conventional cardioprotective agents, bioengineered nanomaterials enable targeted drug delivery to ischemic cardiomyocytes through tunable physicochemical properties. This improves therapeutic efficacy while reducing systemic exposure, providing innovative strategies for MIRI treatment. This review summarizes recent advances in nanomaterial-based MIRI therapies and critically evaluates their clinical translation potential, highlighting both opportunities and challenges.
期刊介绍：
Research serves as a global platform for academic exchange, collaboration, and technological advancements. This journal welcomes high-quality research contributions from any domain, with open arms to authors from around the globe.
Comprising fundamental research in the life and physical sciences, Research also highlights significant findings and issues in engineering and applied science. The journal proudly features original research articles, reviews, perspectives, and editorials, fostering a diverse and dynamic scholarly environment.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
